Page 13 - Sci Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. CORRECTION – VectivBio Announces Closing of $146.6 Million Initial Public Offering VectivBio AGApril 14, 2021 GMT BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by VectivBio Holding AG (Nasdaq: VECT), please note that in the first sentence of the first paragraph, the figure of the additional ordinary shares should be 1,125,000, not 1,250,000. The corrected release follows: VectivBio Holding AG, (“Vectiv” or “VectivBio�...

VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. VYNE Therapeutics Inc. (NASDAQ: VYNE) Q4 2020 Earnings Call Good morning and welcome to the VYNE Therapeutics conference call to discuss the fourth-quarter and full-year 2020 financial results and update. [Operator instructions] Following the company's formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company's request. I will now turn the call over to Michael Woo...

Operator Good evening, and welcome to Oyster Point Pharma's fourth-quarter 2020 earnings conference call. My name is Josh, and I will be your operator today. [Operator instructions] At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma's chief financial officer. Sir, please go ahead. Chief Financial Officer Good evening, everyone, and welcome to the Oyster Point Pharma fourth-quarter earnings conference call for the three months ending December 31, 2020. This evening, we issued a press release containing our fourth-quarter financial results and recent bus...